Loading company
TAKTakeda Pharmaceutical Company Limited$34.4BABuilt from BGM Group Ltd.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
The themes BGM is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BGM · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
$8.18-6.0%Nov 13 close
Figures through March 31, 2026, from the 6-K filed August 28, 2026
Grade F-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 9 quarters of BGM Group Ltd.’s grade history. The other 7 go back to March 2021.
